03:20 AM EDT, 06/13/2025 (MT Newswires) -- Andrew Cheng, Director, President and Chief Executive Officer, on June 10, 2025, sold 37,837 shares in Akero Therapeutics ( AKRO ) for $2,044,940. Following the Form 4 filing with the SEC, Cheng has control over a total of 556,487 common shares of the company, with 556,487 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000095017025085674/xslF345X05/ownership.xml